Meningiomas are primary central nervous system tumor with the highest prevalence.
Meningiomas have a high recurrence rate in the same location. One of the factors thought to …

The multiplicity of meningiomas or abrupt lesion growth in patients treated with cyproterone
acetate suggests that this progestative treatment may promote lesion growth. We report the …

Epidermal growth factor (EGF) is an important autocrine and/or paracrine mediator of steroid
hormones to stimulate growth and differentiation in mammals. The aim of this study is to …

Purpose: Meningioma is a benign tumor, more frequent in female population. During
pregnancy, distinguishing a meningioma from other common conditions presenting with …

Background The incidence of meningioma is disparate to sex: meningiomas are more
common in women than in men, especially in middle-aged women. Understanding the …

The hormonally active nature of intracranial meningioma has prompted research examining
the risk of tumorigenesis in patients using hormonal contraception. Studies exploring …

Discussion: Cerebral meningioma is usually a slow-growing tumor; however, during
pregnancy, the mass may expand rapidly due to hormonal receptor expression. The …

Objective Presence of steroid hormone receptors in meningiomas is well-known, but their
correlation with tumour behaviour is unclear. The purpose of this study was to assess the …

Background Meningiomas are mostly benign and slow-growing neoplasms of the central
nervous system. Spinal meningiomas account for up to 45% of all intradural spinal tumors in …

Giant intracranial meningiomas (GIMs) are a subgroup of meningiomas with huge
dimensions with a maximum diameter of more than 5 cm. The mechanisms by which a …